Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Reviva Pharmaceuticals Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 13 | 19 | +6 |
| Shares | 1.87M | 920.8K | −945.6K (−50.7%) |
| Value | $2.05M | $1.65M | −$402.0K (−19.6%) |
New holders (8)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 83,652 | $133.0K | 0.00% |
| Susquehanna International Group, LLP | 72,218 | $115.0K | 0.00% |
| Virtu Financial LLC | 46,119 | $73.0K | 0.01% |
| Citadel Advisors LLC | 40,232 | $64.0K | 0.00% |
| Sabby Management, LLC | 30,000 | $48.0K | 0.10% |
| Jane Street Group, LLC | 17,180 | $27.0K | 0.00% |
| Quadrature Capital Ltd | 11,839 | $19.0K | 0.00% |
| Royal Bank of Canada | 4 | $0 | 0.00% |
Sold out (2)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tang Capital Management LLC | 1,200,000 | $1.32M |
| Renaissance Technologies LLC | 18,200 | $20.0K |